Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07526987) titled 'Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis' on April 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Beijing Tiantan Hospital

Condition: Ischaemic Stroke

Intervention: Drug: Minocycline Hydrochloride Capsule (50 mg per capsule)

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: May 1, 2026

Target Sample Size: 934

Countries of ...